Drug Profile
Influenza A virus vaccine H1N1 - Panacea Biotec
Alternative Names: Inactivated H1N1 split virion influenza vaccine; Monovalent H1N1 influenza A virus vaccine; Pandy-flu; PandyfluLatest Information Update: 21 Apr 2016
Price :
$50
*
At a glance
- Originator Panacea Biotec
- Class Influenza A virus H1N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H1N1 subtype
Most Recent Events
- 20 Apr 2016 No recent reports on development identified - Registered for Influenza-A virus H1N1 subtype (Prevention) in India (IM)
- 08 Feb 2011 Registered for Influenza-A virus H1N1 subtype in India (IM)
- 01 May 2010 Phase-II/III clinical trials in Influenza-A virus H1N1 subtype in India (IM)